Cargando…
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy
Therapy with nucleic acid polymers (NAPs), tenofovir disoproxil fumarate (TDF), and pegylated interferon (pegIFN) achieve high rates of HBsAg loss/seroconversion and functional cure in chronic hepatitis B virus (HBV) infection. The role of hepatitis B surface antigen (HBsAg) seroconversion and inact...
Autores principales: | Bazinet, Michel, Anderson, Mark, Pântea, Victor, Placinta, Gheorghe, Moscalu, Iurie, Cebotarescu, Valentin, Cojuhari, Lilia, Jimbei, Pavlina, Iarovoi, Liviu, Smesnoi, Valentina, Musteata, Tatina, Jucov, Alina, Dittmer, Ulf, Gersch, Jeff, Holzmayer, Vera, Kuhns, Mary, Cloherty, Gavin, Vaillant, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557319/ https://www.ncbi.nlm.nih.gov/pubmed/34558823 http://dx.doi.org/10.1002/hep4.1767 |
Ejemplares similares
-
HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022) -
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020) -
Imported acute viral hepatitis E. case report
por: Cojuhari, Lilia, et al.
Publicado: (2013) -
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg
por: Shekhtman, Louis, et al.
Publicado: (2020) -
Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)